Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use →

First bioequivalent to ONSIOR® (robenacoxib) Injection equips veterinarians with new, cost-effective NSAID (nonsteroidal anti-inflammatory) option for controlling postoperative pain and inflammation with certain surgical procedures in dogs…